Upadacitinib Impurity 12--(3R,4S)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide
1310726-59-0
Pharmaceutical Grade
90%
Shanghai Port or Shenzhen Port
H&D
A temperature-controlled box with a capacity of up to 10g
2025-01-26
Drug impurity reference,Impurity reference,Reference substance,impurity
-
Product Description
-
Seller Information
-
DescriptionBasic Info
-
Product Name:
(3R,4S)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide
CAS No.:1310726-59-0
Molecular Formula:C17H19F3N6O
Exact Mass:380.157
Categories:
Characteristics-
PSA:
78.32
XLogP3:3.2367
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Drug impurity reference,Impurity reference,Reference substance,impurity
-
Location:
Hengfeng Wanda (Hubei) Pharmaceutical Technology Co., LTD., Hongshan District, Wuhan City, Hubei Province, China
-
Payment Terms:
TT against copy of documents,100% TT in advance
-
Average lead Time:
150
-
Total Annual Revenue:
$5 million-$10 million
-
Total Employees:
51-100
-
Year of Establishment:
2023
-
Certifications:
Brand certification certificate,QUALITY MANAGEMENT SYSTEM CERTIFICATE
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product